Results 211 to 220 of about 221,113 (351)

The Vietnamese swine as a translational model of invasive ductal carcinoma of the breast. [PDF]

Animal Model Exp Med
Vera-Tizatl CE, Vera-Hernández A, Leija-Salas L, Vega-López MA, Ramírez-Estudillo MDC, Fariña GIG, Vera-Tizatl AL.   +6 more
europepmc   +1 more source

Reprogramming SREBP1‐dependent lipogenesis and inflammation in high‐risk breast with licochalcone A: A novel path to cancer prevention

International Journal of Cancer, EarlyView.
What's New? Endocrine drugs repurposed from treatment protocols are the primary medications available for breast cancer (BC) prevention in at‐risk women. Adverse effects, however, significantly minimize uptake and prevention impact. Here, the authors investigated licochalcone A (LicA), a non‐endocrine anti‐inflammatory agent with reported hematologic ...
Atieh Hajirahimkhan, Elizabeth T. Bartom, Carolina H. Chung, Xingyu Guo, Kyli Berkley, Seyyedmohsen Hosseinibarkooie, Zahra Assadi, Shao Huan Samuel Weng, Raymond Moellering, Oukseub Lee, Ruohui Chen, Wonhwa Cho, Sriram Chandrasekaran, Susan E. Clare, Seema A. Khan   +14 more
wiley   +1 more source

Development and validation of a nomogram for differentiating granulomatous lobular mastitis from ductal carcinoma in situ. [PDF]

Front Oncol
Li Y, Su L, Zhang Q, Liu Z.
europepmc   +1 more source

Real‐world efficacy and toxicity of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma according to IMDC risk criteria—A multi‐center retrospective analysis on behalf of the GUARDIANS group

International Journal of Cancer, EarlyView.
What's New? The combination of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma has demonstrated durable response and tolerability in clinical trials. However, inclusion criteria for clinical studies are restrictive, and patients in the real‐world setting tend to have more comorbidities.
Hendrik Dinkel, Linus Materna, Ramona Stelmach, Stefanie Zschäbitz, Stephanie Neuberger, Can D. Aydogdu, Jozefina Casuscelli, Timo Egenolf, Matteo Silberg, Julie Steinestel, Arne Strauss, Florian Kirchhoff, Marit Ahrens, Pia Paffenholz, Richard Cathomas, Berna C. Özdemir, Christopher Gossler, Philipp Ivanyi, Marc Rehlinghaus, Thomas Hilser, Viktor Grünwald, Katrin Schlack   +21 more
wiley   +1 more source

Multimodal Imaging of Ductal Carcinoma In Situ: A Single-Center Study of 75 Cases. [PDF]

Med Sci (Basel)
Urraro F, Giordano N, Patanè V, Brunese MC, Varelli C, Russo C, Brunese L, Cappabianca S.   +7 more
europepmc   +1 more source

Relationship between the expression of Notch1 and EZH2 and the prognosis of breast invasive ductal carcinoma

, 2016
Linjing Zhao, Qiuju Zhang, Xin Luan, Xu Huang, Shuai Zhao, Hengqiang Zhao   +5 more
openalex   +1 more source

Quality‐adjusted life years in the presence and absence of organized mammographic screening using data from BreastScreen Norway

International Journal of Cancer, EarlyView.
What's New? Although mammographic screening can reduce breast cancer mortality and extend life, some studies have found a negative impact on net quality‐adjusted life years (QALYs). Here, the authors estimated net QALYs associated with biennial mammographic screening for women aged 50–69 years in Norway under various scenarios.
Rick Groeneweg, Nicolien T. van Ravesteyn, Lindy M. Kregting, Giske Ursin, Solveig Hofvind, Nataliia Moshina   +5 more
wiley   +1 more source

Concurrent invasive ductal carcinoma and ductal carcinoma <i>in situ</i> arising inside and outside a breast hamartoma: A case report. [PDF]

World J Clin Cases
Wei L, Tian Z, Wang ZY, Liu WJ, Li HB, Zhang Y.   +5 more
europepmc   +1 more source

Breast cancer incidence and survival by subtype, stage at diagnosis and socioeconomic deprivation among young women in the Community of Madrid, Spain

International Journal of Cancer, EarlyView.
What's New? Breast cancer comprises a heterogeneous group of diseases with differing features and survival outcomes. In particular, survival is affected by socioeconomic status, though age‐specific patterns remain unknown. Here, the authors examined differences in breast cancer incidence and survival specifically among young women in the Community of ...
Candela Pino‐Rosón, Sonia Ávila‐Arroyo, David Parra‐Blázquez, María J. Soto Zabalgogeazcoa, Daniel Moñino, Raquel López‐González, Clotilde Sevilla‐Hernández, Cristina González‐Blázquez, Miguel Martín, Nuria Aragonés   +9 more
wiley   +1 more source

SEPT9 methylation as a diagnostic and predictive biomarker in the progression of ductal carcinoma in situ to invasive breast cancer. [PDF]

Sci Rep
Guo Y, Zhou X, Xu H, Wang G.
europepmc   +1 more source